Literature DB >> 1312229

The pathogenesis of cerebral gliomatous cysts.

P N Lohle1, I T Verhagen, A W Teelken, E H Blaauw, K G Go.   

Abstract

In this study, the authors have examined the mechanism of the formation of tumor cysts. Cyst fluid samples were obtained during surgery and by percutaneous aspiration from 22 patients with cystic cerebral gliomas. The concentration of protein was measured in the cyst fluid and blood plasma. Analysis of brain tumor cyst fluids revealed that plasma proteins constituted a major fraction (92%) of cyst fluid proteins; moreover, the protein fractions occurred in concentrations (relative to the plasma concentrations) that were around 50-fold of those in cerebrospinal fluid. This strongly indicates blood-brain barrier disruption. Evidence from computed tomographic and magnetic resonance imaging scans as well as from electron microscopy of tumor cyst walls suggests the transition of spongy edematous tissue in or around tumors into the contents of associated cysts. Pathophysiologically, blood-brain barrier breakdown is inherent to the occurrence of vasogenic brain edema. It is therefore plausible that the development of cysts is related to peritumoral vasogenic edema.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312229     DOI: 10.1227/00006123-199202000-00005

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

1.  Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion.

Authors:  B Frankel; S L Longo; G W Canute
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Increased expression of aquaporin 1 in human hemangioblastomas and its correlation with cyst formation.

Authors:  Yizhao Chen; Osamu Tachibana; Masashi Oda; Ruxiang Xu; Jun-Ichiro Hamada; Junkoh Yamashita; Nobuo Hashimoto; Jun A Takahashi
Journal:  J Neurooncol       Date:  2006-11-01       Impact factor: 4.130

3.  Development of a small solid cerebellar haemangioblastoma into a large pseudocyst with a mural nodule in a patient without VHL; the importance of regular follow-up.

Authors:  Hansol Kim; Jin-Deok Joo; Young-Hoon Kim; Chae-Yong Kim
Journal:  BMJ Case Rep       Date:  2014-11-26

4.  Migration of human glioma cells in response to tumour cyst fluids.

Authors:  A Giese; F Schröder; A Steiner; M Westphal
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 5.  Intratumoral drug delivery with nanoparticulate carriers.

Authors:  Hillary Holback; Yoon Yeo
Journal:  Pharm Res       Date:  2011-01-07       Impact factor: 4.200

6.  The pathogenesis of cysts accompanying intra-axial primary and metastatic tumors of the central nervous system.

Authors:  P N Lohle; H A Wurzer; P J Seelen; L M Kingma; K G Go
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

7.  Glioblastoma microenvironment contains multiple hormonal and non-hormonal growth-stimulating factors.

Authors:  Daniel Dahlberg; Jutta Rummel; Sonia Distante; Gustavo Antonio De Souza; Maria Ekman Stensland; Espen Mariussen; Helge Rootwelt; Øyvind Voie; Bjørnar Hassel
Journal:  Fluids Barriers CNS       Date:  2022-06-04

8.  Rapid increase in cystic volume of an anaplastic astrocytoma misdiagnosed as neurocysticercosis: A case report.

Authors:  Hong-Jiang Li; Hong-Xiu Han; Dong-Fu Feng
Journal:  Oncol Lett       Date:  2016-08-10       Impact factor: 2.967

9.  Neuropathological and neurophysiological effects of interstitial white matter autologous and non-autologous protein containing solutions: further evidence for a glioma derived permeability factor.

Authors:  I R Whittle; J W Ironside; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

10.  Platelet-derived growth factor (PDGF) in neoplastic and non-neoplastic cystic lesions of the central nervous system and in the cerebrospinal fluid.

Authors:  M Nistér; P Enblad; G Bäckström; T Söderman; L Persson; C H Heldin; B Westermark
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.